科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06990 科伦博泰生物-B

休市中 02-20 16:08:38

416.600

+4.000

+0.97%

最高419.800	最低407.600	成交量9.55万
今开410.400	昨收412.600	日振幅2.96%
总市值971.45亿	流通市值678.10亿	总股本2.33亿
成交额3,963万	换手率0.06%	流通股本1.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科伦博泰生物-B","latestPrice":416.6,"timestamp":1771574918009,"preClose":412.6,"halted":0,"volume":95500,"delay":0,"changeRate":0.009694619486185167,"floatShares":162769979,"shares":233185969,"eps":-1.203559,"marketStatus":"休市中","change":4,"latestTime":"02-20 16:08:38","open":410.4,"high":419.8,"low":407.6,"amount":39632120,"amplitude":0.029569,"askPrice":416.6,"askSize":6300,"bidPrice":415.6,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-3.508831,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771810200000},"marketStatusCode":7,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":412.6,"openAndCloseTimeList":[[1771551000000,1771560000000],[1771563600000,1771574400000]],"volumeRatio":0.22509739500416204,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06990/wiki","defaultTab":"wiki","newsList":[{"id":"2612828024","title":"每日卖空追踪 | 科伦博泰生物-B 02月16日卖空量成交9800股，卖空比例为32.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612828024","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612828024?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230634,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月16日，跌1.43%，卖空量成交9800股，较上一交易日减少89.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163516a700e050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163516a700e050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2610923012","title":"科伦博泰生物-B逆势下跌3.33%，受板块走弱及机构观点分歧影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2610923012","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610923012?lang=zh_cn&edition=full","pubTime":"2026-02-12 19:14","pubTimestamp":1770894840,"startTime":"0","endTime":"0","summary":"经济观察网 根据2026年2月12日的市场公开信息，科伦博泰生物-B当日逆势下跌3.33%，收报423.40港元，成交额2.08亿港元。其下跌主要受以下因素影响：板块变化情况恒生指数当日下跌0.86%，恒生科技指数跌幅达1.65%，生物技术板块整体下跌0.84%。机构观点美银证券2月12日发布研报，虽将公司目标价从470港元上调至479港元，但重申“中性”评级，并因国家医保目录价格调整下调了Sac-TMT的年度治疗费用假设，将2026年及2027年收入预测分别下调5%及6%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-02-12/doc-inhmqmpx9517434.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-02-12/doc-inhmqmpx9517434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2610967635","title":"每日卖空追踪 | 科伦博泰生物-B 02月11日卖空量成交5.74万股，卖空比例为11.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610967635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610967635?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:30","pubTimestamp":1770798641,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月11日，涨0.18%，卖空量成交5.74万股，较上一交易日减少30.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163607a6ee205e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163607a6ee205e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2610967515","title":"科伦博泰生物-B02月11日主力净流入282.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610967515","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610967515?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:15","pubTimestamp":1770797721,"startTime":"0","endTime":"0","summary":"02月11日, 科伦博泰生物-B股价涨0.18%，报收438.00元，成交金额2.1亿元，换手率0.30%，振幅4.76%，量比1.10。科伦博泰生物-B今日主力资金净流入282.1万元，上一交易日主力净流出250.1万元。该股近5个交易日上涨1.70%，主力资金累计净流入626.4万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出3078.3万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161617a4971bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161617a4971bb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2610605217","title":"中金：维持科伦博泰生物-B(06990)跑赢行业评级 目标价550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610605217?lang=zh_cn&edition=full","pubTime":"2026-02-11 09:41","pubTimestamp":1770774116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，基本维持科伦博泰生物-B2025年/2026年归母净利润预测不变，得益于sac-TMT海外商业化，该行引入2027年归母净利润预测6.3亿元。该行维持跑赢行业评级，基于DCF模型，维持目标价550港元不变，较当前股价有30.0%的上行空间。根据公司披露，在所有乳腺癌病例中HR+/HER2-分子亚型约占70%。目前CDK4/6抑制剂联合内分泌治疗已成为1L标准疗法，但后线选择空间收窄，化疗临床获益有限。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990"],"gpt_icon":0},{"id":"2610268695","title":"恒生医疗保健指数升2.17%  医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610268695?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:59","pubTimestamp":1770688793,"startTime":"0","endTime":"0","summary":"2月8日，信达生物宣布与礼来制药达成战略合作，携手推进肿瘤及免疫领域创新药物的全球研发。2026年，继续看好中国创新药出海的产业趋势，继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会，期待JPM大会、ASCO等带来数据更新和BD催化。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f73ea90e21e93e4b02cf2f8986a9c30","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","LU2476274720.SGD","LU0516422366.SGD","LU1046422090.SGD","09969","01877","LU0516423174.USD","09995","02162","LU0634319403.HKD","03347","09688","LU0181495838.USD","159992","LU1969619763.USD","02269","LU2045819591.USD","LU1720050803.USD","LU0348825331.USD","06978","BK1587","LU0502904849.HKD","LU0043850808.USD","09926","06990","LU1688375341.USD","LU0140636845.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU0572944931.SGD","159506","BK1161","LU2242644610.SGD","LU0051755006.USD","02359","LU1961090484.USD","LU2476274308.USD","02696","LU0856984785.SGD","02268","01548","159938","LU0359202008.SGD","09939","01801","LU2039709279.SGD","LU0417516902.SGD","LU0196878994.USD","LU0417516738.SGD","LU0823426308.USD"],"gpt_icon":1},{"id":"2610568695","title":"高盛：今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2610568695","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610568695?lang=zh_cn&edition=full","pubTime":"2026-02-09 14:08","pubTimestamp":1770617323,"startTime":"0","endTime":"0","summary":"今年要获得超越行业的回报，更依赖于关键数据公布、实际成交，以及盈利兑现或转折点的能见度。该行对医疗器械板块维持中性看法，虽然行业已触底，但需时逐步复苏；推荐买时代天使及威高股份。医疗服务板块方面，该行仍持相对谨慎态度，因成本控制措施的持续影响，以及疲弱的消费周期；下调海吉亚医疗评级至“中性”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0196878994.USD","02268","LU0708995583.HKD","159891","LU2488822045.USD","BK1589","06990","HK0000320264.USD","HK0000320223.HKD","LU2242644610.SGD","LU1046422090.SGD","CDMO","BK1161","BK4139","LU2125910500.SGD","HK0000165453.HKD","LU0052750758.USD","BK1576","03692","BK1191","BK1583","02359","02696","HK0000306685.HKD","LU2045819591.USD","BK1141","SG9999014674.SGD","HK0000306701.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2609352096","title":"科伦博泰重磅药物，获批新适应症！","url":"https://stock-news.laohu8.com/highlight/detail?id=2609352096","media":"药通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609352096?lang=zh_cn&edition=full","pubTime":"2026-02-08 12:06","pubTimestamp":1770523610,"startTime":"0","endTime":"0","summary":"2月6日，NMPA官网显示，科伦博泰TROP2 ADC芦康沙妥珠单抗获批一项新适应症，用于治疗既往接受过内分泌治疗且在晚期或转移性阶段接受过其他系统治疗的不可切除的局部晚期或转移性激素受体阳性（HR+）且人表皮生长因子受体2阴性乳腺癌成人患者。2022年5月，科伦博泰与默沙东签署合作协议，授予后者在大中华区以外的所有地区开发、使用、制造及商业化芦康沙妥珠单抗的独家权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260208124748a48a1ddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260208124748a48a1ddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1100448776","title":"科伦博泰生物-B宣布萨坦珠单抗（Sac-TMT）获NMPA批准用于HR+/HER2-乳腺癌，为第四项适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1100448776","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100448776?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:04","pubTimestamp":1770368678,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B宣布，其创新药物萨坦珠单抗已获得国家药品监督管理局批准，用于治疗HR阳性、HER2阴性乳腺癌患者。这是该药物在中国获批的第四项适应症，标志着其在肿瘤治疗领域的应用进一步扩展。此次获批基于临床试验数据，显示萨坦珠单抗在HR+/HER2-乳腺癌患者中表现出显著的疗效和可控的安全性。科伦博泰生物-B持续致力于创新药物的研发与商业化，此次新适应症的获批将有望提升萨坦珠单抗的市场潜力，并为公司未来业绩增长注入动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2609639435","title":"科伦博泰生物-B(06990)：核心产品TROP2ADC芦康沙妥珠单抗(sac-TMT)获国家药品监督管理局批准第四项适应症上市，用于治疗2L+HR+/HER2-乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2609639435","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609639435?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:36","pubTimestamp":1770366971,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布公告，近日，本公司靶向人滋养细胞表面抗原2的抗体偶联药物芦康沙妥珠单抗(佳泰莱)的一项新增适应症上市申请已获中国国家药品监督管理局批准，用于治疗既往接受过内分泌治疗且在晚期疾病阶段接受过至少一线化疗的不可切除或转移性的激素受体阳性(HR+)且人类表皮生长因子受体2阴性乳腺癌成人患者。此次获批的至少经一线化疗治疗HR+/HER2-BC是芦康沙妥珠单抗在中国上市的第四项适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HR","LU0196878994.USD","BK4225","06990","BK4203","BK1161"],"gpt_icon":0},{"id":"1128888972","title":"科伦博泰生物-B：Trop2 ADC药物Sacituzumab Tirumotecan获NMPA批准上市，适应症扩展至第四项","url":"https://stock-news.laohu8.com/highlight/detail?id=1128888972","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128888972?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:35","pubTimestamp":1770366912,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B宣布，其靶向Trop2的抗体偶联药物（ADC）Sacituzumab Tirumotecan已获得国家药品监督管理局（NMPA）批准上市。这是该药物获批的第四项适应症，标志着其在临床应用范围的进一步扩大。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1109931140","title":"四川科伦博泰生物医药（06990）更新2026年1月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1109931140","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109931140?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:43","pubTimestamp":1770194587,"startTime":"0","endTime":"0","summary":"四川科伦博泰生物医药股份有限公司于2026年2月4日发布2026年1月股份变动月报表，报告期为2026年1月1日至1月31日。公告显示，公司整体股本结构保持稳定，未见新增发行或购回动作。根据月报表，公司截至2026年1月31日的注册股本总额为人民币233,185,969元，具体包括：H股162,769,979股，内资股65,773,800股，非上市外资股4,642,190股。上述各类已发行股份数量均与上月底相同，库存股份数目为零。本次月报表由联席公司秘书周泽剑签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2608352283","title":"每日卖空追踪 | 科伦博泰生物-B 02月04日卖空量成交2.89万股，卖空比例为5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608352283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608352283?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193838,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月04日，涨5.28%，卖空量成交2.89万股，较上一交易日减少62.32%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163832a47b1127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163832a47b1127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2608635243","title":"科伦博泰生物-B02月04日获主力加仓196.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608635243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608635243?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192943,"startTime":"0","endTime":"0","summary":"02月04日, 科伦博泰生物-B股价涨5.28%，报收422.80元，成交金额2.2亿元，换手率0.33%，振幅8.32%，量比1.07。科伦博泰生物-B今日主力资金净流入196.7万元，连续6日净流入，上一交易日主力净流入264.8万元。近一年数据显示，该股主力连续6日净流入后，次日上涨概率为71.43%，平均涨幅为2.98%。该股近5个交易日下跌1.27%，主力资金累计净流入2117.8万元；近20日主力资金累计净流出1514.6万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161932a6d1f1a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161932a6d1f1a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2608829980","title":"科伦博泰生物-B02月03日获主力加仓264.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608829980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608829980?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106539,"startTime":"0","endTime":"0","summary":"02月03日, 科伦博泰生物-B股价涨0.10%，报收401.60元，成交金额1.7亿元，换手率0.26%，振幅3.59%，量比0.88。科伦博泰生物-B今日主力资金净流入264.8万元，连续5日净流入，上一交易日主力净流入144.8万元。该股近5个交易日下跌1.76%，主力资金累计净流入3011.4万元；近20日主力资金累计净流出4612.4万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161908a476af20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161908a476af20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2608104688","title":"每日卖空追踪 | 科伦博泰生物-B 02月02日卖空量成交4.45万股，卖空比例为8.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608104688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608104688?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021038,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月02日，跌3.42%，卖空量成交4.45万股，较上一交易日减少76.28%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163833a6c987ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163833a6c987ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2608450810","title":"百济神州 ≈ 信达生物+科伦博泰+康方生物 ？","url":"https://stock-news.laohu8.com/highlight/detail?id=2608450810","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608450810?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:29","pubTimestamp":1770002959,"startTime":"0","endTime":"0","summary":"截止到2026年2月2日午间市值数据显示：百济神州以约3070亿港元的市值，几乎等同于信达生物、科伦博泰生物与康方生物三者的总和。2025年第三季度，百济神州净利润达1.25亿美元，而去年同期为亏损1.21亿美元。信达生物、科伦博泰和康方生物则仍处于高增长、高投入阶段，其估值包含了风险溢价和未来成长潜力。对于信达生物、科伦博泰和康方生物而言，未来18-24个月是关键的验证期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348783233.USD","BK1589","LU1303224171.USD","LU0348827113.USD","LU2097828474.EUR","BK1500","IE00B543WZ88.USD","LU0348767384.USD","LU0348784397.USD","LU0455707207.USD","LU1720050803.USD","LU2097828805.USD","BK1583","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","LU2097828557.USD","LU0417516571.SGD","LU2097828714.EUR","BK1588","06990","LU0417516902.SGD","LU2476274720.SGD","LU1969619763.USD","LU1251922891.USD","LU0417516738.SGD","LU1794554557.SGD","BK1574","LU1961090484.USD","LU0348766576.USD","01801","LU0196878994.USD","06160","LU0348735423.USD","IE00B5MMRT66.SGD","LU2328871848.SGD","LU0502904849.HKD","LU0588546209.SGD","LU2778985437.USD","LU1770034418.SGD","LU1719994722.HKD","LU0634319403.HKD","LU2242644610.SGD","LU2399975544.HKD","LU0540923850.HKD","09926","LU0561508036.HKD","LU2097828631.EUR","HK0000165453.HKD","LU0348825331.USD"],"gpt_icon":0},{"id":"2607075748","title":"每日卖空追踪 | 科伦博泰生物-B 01月30日卖空量成交3.57万股，卖空比例为8.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607075748","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607075748?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:30","pubTimestamp":1769761839,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月30日，涨0.29%，卖空量成交3.57万股，较上一交易日减少50.42%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164154a46857a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164154a46857a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2607757160","title":"科伦博泰生物-B01月30日获主力加仓1449.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607757160","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607757160?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:15","pubTimestamp":1769760942,"startTime":"0","endTime":"0","summary":"01月30日, 科伦博泰生物-B股价涨0.29%，报收415.40元，成交金额2.1亿元，换手率0.31%，振幅5.75%，量比0.93。科伦博泰生物-B今日主力资金净流入1449.9万元，连续3日净流入，上一交易日主力净流入61.6万元。该股近5个交易日下跌2.42%，主力资金累计净流出1096.6万元；近20日主力资金累计净流出7389.6万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162050a6bf361f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162050a6bf361f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2607674464","title":"每日卖空追踪 | 科伦博泰生物-B 01月28日卖空量成交4.23万股，卖空比例为7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607674464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607674464?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589038,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月28日，涨3.61%，卖空量成交4.23万股，较上一交易日减少52.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128165056a45f8f4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128165056a45f8f4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://kelun-biotech.com","stockEarnings":[{"period":"1week","weight":-0.0048},{"period":"1month","weight":-0.0298},{"period":"3month","weight":-0.0234},{"period":"6month","weight":-0.1072},{"period":"1year","weight":1.2066},{"period":"ytd","weight":0.0622}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0065},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0424},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0305}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四川科伦博泰生物医药股份有限公司是一家主要从事新药业务的研发、生产和销售的中国公司。该公司主要从事肿瘤学、免疫学及其他治疗领域的创新药物的研发、制造及商业化。该公司的产品为抗体药物偶联物（ADC）SKB264及A166。该公司产品主要用于乳腺癌、非小细胞肺癌、胃肠道癌等非肿瘤疾病的治疗。","exchange":"SEHK","name":"科伦博泰生物-B","nameEN":"SKB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科伦博泰生物-B,06990,科伦博泰生物-B股票,科伦博泰生物-B股票老虎,科伦博泰生物-B股票老虎国际,科伦博泰生物-B行情,科伦博泰生物-B股票行情,科伦博泰生物-B股价,科伦博泰生物-B股市,科伦博泰生物-B股票价格,科伦博泰生物-B股票交易,科伦博泰生物-B股票购买,科伦博泰生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}